The role of transesophageal echocardiography (TEE) in the evaluation of acute stroke patients is still ill-defi ned. We conducted a prospective observational study to fi nd the prevalence of TEE fi ndings that indicate anticoagulation as benefi cial, in acute ischemic stroke patients without indication for anticoagulation based on clinical, electrocardiographic and transthoracic echocardiography (TTE) fi ndings.
Introduction
The role of transesophageal echocardiography (TEE) in the evaluation of acute stroke patients is still ill-defi ned (Adams et al 2003; Hack et al 2003) .
While some studies conclude that TEE should be mandatory on all ischemic stroke patients, based on its cost-effectiveness (McNamara et al 1997) and sensitivity for fi ndings that change clinical management (coumadin instead of aspirin) (Blum et al 2004) , others fi nd that TEE abnormalities are found mostly in patients already with clinical, electrocardiographic or transthoracic echocardiography (TTE) data that would justify anticoagulation, and are rare in patients with sinus rhythm and with a normal TTE (Leung et al 1995; Cabral et al 2001; Agmom and Khandheria 2002) . As a consequence, the usefulness of TEE fi ndings for the clinical management of ischemic stroke patients has been challenged, but not defi ned, with some authors defending TEE only on patients with abnormal TTE (Leung et al 1995) , with a normal TTE (Nighoghossian 1995) , on an individual patient basis (Cabral et al 2001) , or questioning its usefulness in the management of any ischemic stroke patient (Warner and Momah 1996) .
The aim of our study was to fi nd the prevalence of TEE fi ndings that indicate anticoagulation as benefi cial, in acute ischemic stroke patients without indication for anticoagulation based on clinical, electrocardiographic, and TTE fi ndings.
Methods
This was a prospective observational study, carried out from April 13, 2004 to October 11, 2005 . The study was approved by our hospital ethics committee. Informed consent was obtained from all patients.
Patients
All patients referred to our laboratory simultaneously for TEE and TTE were enrolled in the study. Patients were excluded if the diagnosis was not acute ischemic stroke, or if they had an indication for anticoagulation based on clinical and electrocardiographic or TTE data.
The diagnosis of stroke was made by the referring physicians, based on clinical data and brain CT.
Echography
All the echographic studies were performed by the authors, on a Vivid 3 System, General Electric.
Transthoracic echocardiography was performed using a 2.5-MHz transducer for M-mode, 2D, and Doppler, according to the recommendations of the American Echocardiography Society (Henry et al 1980) .
Transesophageal echocardiography was performed using a multiplane 3.5 to 6.5 MHz probe, according to standard protocols (Seward et al 1988) . The presence of the following potential sources of embolism was specifi cally examined: (a) left atrial spontaneous echo contrast and thrombus; (b) atheroma in the thoracic aorta; (c) patent foramen ovale and atrial septal aneurysm; and (d) others, including valvular vegetations and intracardiac masses. Left atrial spontaneous echo contrast was diagnosed by the presence of characteristic dynamic smokelike swirling echo in the left atrium or the atrial appendage, distinct from background white noise due to excessive gain (Black et al 1991) . Left atrial thrombus was diagnosed by the presence of an echodense mass in the left atrium or the left atrial appendage, distinct from the endocardium and the pectinate muscles of the left atrial appendage (Beppu et al 1984) . The presence of atheroma in the thoracic aorta was examined. Atheroma that were mobile, pedunculated, or protruding Ն5 mm into the lumen were classifi ed as complex atheroma (Karalis et al 1985; Katz et al 1992) . All other sessile atheroma Ͻ5 mm in thickness were classifi ed as simple atheroma. The interatrial septum was examined for patent foramen ovale, atrial septal defect, and atrial septal aneurysm. Color doppler, without and with Valsalva manoeuvre, and bubble contrast study with agitated saline, also without and with Valsalva manoeuvre, were performed in all patients to look for interatrial shunting. Bubbles appearing in the left atrium within three cardiac cycles or observed traversing the interatrial septum constituted a positive study for shunting. Atrial septal aneurysm was defi ned as a thin-walled area in the region of the fossa ovalis with a base of at least 1.5 cm and an excursion with the cardiac cycle of at least 1.5 cm (Hanley et al 1985) . Care was taken to distinguish a true atrial septal aneurysm from a hypermobile interatrial septum.
Indications for anticoagulation
TTE fi ndings that were considered to indicate anticoagulation as benefi cial (Tribolet de Abreu et al 2005) were defi ned as: mitral valve stenosis with an enlarged (Ͼ55 mm) left atria, valve prosthesis, left ventricular systolic dysfunction (with an estimated ejection fraction Ͻ35%), dilated cardiopathy, previous myocardial infarction (with left ventricular wall dyskinesis), left atria or left ventricle masses.
TEE fi ndings that were considered to indicate anticoagulation as benefi cial were defi ned as: left atrial spontaneous echo contrast and thrombus (Blum et al 2004) , complex aortic atheroma (Amarenco et al 1994; Jones et al 1995) , simultaneous patent foramen ovale and atrial septal aneurysm (Mas et al 2001; Kizer et al 2005) , thrombus on any heart chamber, valve, or the aorta.
Statistical analysis
The program Statistical Package for the Social Sciences version 12.0 for Windows was used as a database.
Results
During the study period, 143 patients were sent to our laboratory for both TTE and TEE. In addition to 28 repeated examinations, a total of 31 patients were excluded for nonstroke diagnosis and for indications of anticoagulation before the performance of transesophageal echocardiography (Figure 1) , leaving 84 patients included in the study.
The baseline characteristics and risk factors of the study patients are shown in Table 1. A total of 27 (32.1%) patients had TEE fi ndings that might indicate anticoagulation as benefi cial (Table 2) , three of which had more than one fi nding (left atrial spontaneous echo contrast and complex aortic atheroma [1 patient], thrombus in the aortic artery wall and complex aortic atheroma [2 patients]). Table 3 ). Only one of them was prospective (Harloff 2006) , three included patients without a previous TTE (Warner and Momah 1996; Palazzuoli 2000; Tatani 2001) , and two included patients with atrial fi brilation (Warner and Momah 1996; Harloff 2006 ). Only two of the studies specifi ed the number of patients who had simultaneous patent foramen ovale and atrial septal aneurysm (Tatani 2001; Harloff 2006 ). This fact is relevant, since anticoagulation is considered benefi cial only in patients with both these abnormalities (Mas et al 2001; Kizer et al 2005) .
Therapeutic implications of transesophageal echocardiography
The most recent of these studies, by Harloff and colleagues (2006), was a prospective study in which TEE was performed on 503 out of 564 consecutive ischemic stroke patients, including patients excluded from our study, such as patients already with indications for anticoagulation, as atrial fi brilation and other types of cardioembolic stroke, and patients with contraindications against oral anticoagulation. They found spontaneous echo contrast in 11.5%, complex aortic atheroma in 19.7%, thrombus in 7.2% and simultaneous patent foramen ovale and atrial septal aneurysm in 9%. They concluded that "TEE is indispensable in all patients being candidates for oral anticoagulation".
Our study patients were a selected group who were referred for TEE by the attending physician. During our study, a total of 855 patients were admitted to our hospital with a Of the 7 patients with thrombus, 4 had thrombus in the aortic valve leafl ets, and three patients had thrombus in the aortic artery wall.
Discussion
In our study, TEE had fi ndings that might indicate anticoagulation as benefi cial in 32.1% of our population of ischemic stroke patients, without other indications for anticoagulation by clinical, electrocardiographic or TTE data.
We found seven similar published studies (Leung et al 1995; Warner and Momah 1996; Palazzuoli 2000; Cabral et al 2001; Tatani 2001; Ward 2006; Harloff 2006;  (Amarenco et al 1994; Jones et al 1995; Mas et al 2001; Blum et al 2004; Kizer et al 2005) . The superiority of TEE over TTE for diagnosing these abnormalities has also been demonstrated (McNamara et al 1997; Blum et al 2004) , and confi rmed in our study. The prevalence of these abnormalities in a large unselected population of consecutive ischemic stroke patients has recently been studied by Harloff and colleagues (2006) . Our results seem to confi rm their fi ndings, but on a more selected population of patients with no other indication for anticoagulation. Based on our study and on the study by Harloff and colleagues, we propose an algorithm for the use of ultrasonographic studies on ischemic stroke patients without contraindications for long term anticoagulation (Figure 2) .
The results of our study show that TEE can have therapy implications in 32.1% of ischemic stroke patients in sinus rhythm and with a previous TTE with no indication for anticoagulation. 
